secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cadrenal Therapeutics, Inc. (CVKD)
CIK:        0001937993
Form:       8-K
Filed at:   2024-09-05T23:59:59+00:00
Accession:  0001213900-24-076144
Event type: regulatory
Sentiment:  positive
Materiality: 0.40
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cadrenal Therapeutics regains Nasdaq minimum bid price compliance
-----------------------------------------------------------------

- Received Nasdaq letter on Sept 5 confirming closing bid price >=$1 for 10 consecutive business days (Aug 20-Sept 4).
- Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and the matter is closed.
- No further action required; stock continues trading on Nasdaq Capital Market under CVKD.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1937993/000121390024076144/0001213900-24-076144-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1937993/000121390024076144/ea021370601-8k_cadrenal.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-076144

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer